10549Background: We conducted an open label, single arm phase II clinical trial with irinotecan and cisplatin (I/C) for pediatric patients with glial tumors (EudraCT:2009-010742-59). Methods: Patie... Click to show full abstract
10549Background: We conducted an open label, single arm phase II clinical trial with irinotecan and cisplatin (I/C) for pediatric patients with glial tumors (EudraCT:2009-010742-59). Methods: Patie...
               
Click one of the above tabs to view related content.